Huntington S - Search Results

1

An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing.

Dombrowski C, Bourgain C, Ma Y, Meiwald A, Pinsent A, Weynand B, Turner KME, Huntington S, Adams EJ, Bogers J, Croes R, Sahebali S. Dombrowski C, et al. Among authors: huntington s. Eur J Cancer Prev. 2024 May 1;33(3):262-270. doi: 10.1097/CEJ.0000000000000856. Epub 2023 Nov 23. Eur J Cancer Prev. 2024. PMID: 37933867 Free PMC article.

2

An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France and Spain.

Miners L, Huntington S, Lee N, Turner KME, Adams E. Miners L, et al. Among authors: huntington s. BMC Pulm Med. 2023 Jun 21;23(1):220. doi: 10.1186/s12890-023-02516-2. BMC Pulm Med. 2023. PMID: 37344852 Free PMC article.

3

Correction to: an economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France and Spain.

Miners L, Huntington S, Lee N, Turner KME, Adams E. Miners L, et al. Among authors: huntington s. BMC Pulm Med. 2023 Aug 11;23(1):296. doi: 10.1186/s12890-023-02572-8. BMC Pulm Med. 2023. PMID: 37568141 Free PMC article. No abstract available.

4

Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.

Puri Sudhir K, Kagenaar E, Meijer M, Hesselink AT, Adams E, Turner KME, Huntington S. Puri Sudhir K, et al. Among authors: huntington s. Diagnostics (Basel). 2023 Dec 6;13(24):3612. doi: 10.3390/diagnostics13243612. Diagnostics (Basel). 2023. PMID: 38132196 Free PMC article.

5

Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia.

Huntington SF, Rhodes JM, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Marx SE, Doshi JA. Huntington SF, et al. JCO Oncol Pract. 2024 Dec 20:OP2400220. doi: 10.1200/OP.24.00220. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39705617

6

Cost-effectiveness of Enasidenib versus conventional care for older patients with IDH2-mutant refractory/relapsed AML.

Alhajahjeh A, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel JM, Mendez L, Huntington SF, Stahl M, Goshua G, Bewersdorf JP, Zeidan AM. Alhajahjeh A, et al. Among authors: huntington sf. Leuk Lymphoma. 2024 Nov 19:1-9. doi: 10.1080/10428194.2024.2426073. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39560957

7

Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.

Zelikson V, Gurumurthi A, Sawalha Y, Annunzio K, Saha A, Dong N, Qualls D, Amoozgar B, Kahl B, Baird J, Challa P, Huntington SF, Santos J, Bair S, Narkhede M, Li S, Frosch Z, Ho C, Smith SD, Winter A, Landsburg D, Furqan F, Hamadani M, Baird K, Romancik J, Alharthy H, Law J, Bojanini L, Advani R, Hu B, Johnson PC, Grover NS, Merril M, Crombie JL, Shafagati N, Sterling C, Nastoupil LJ, Epperla N, Ayers EC. Zelikson V, et al. Among authors: huntington sf. Haematologica. 2024 Nov 14:0. doi: 10.3324/haematol.2024.285977. Online ahead of print. Haematologica. 2024. PMID: 39540227 Free article.

8

Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy.

Huntington SF, Lin D, Lafeuille MH, Thompson-Leduc P, Shah A, Kim N, Hester L, Tardif-Samson A, Moore B, Fowler J, Marshall A, Zhang X, Gifkins D, Wu B. Huntington SF, et al. Pharmacol Res Perspect. 2024 Dec;12(6):e70024. doi: 10.1002/prp2.70024. Pharmacol Res Perspect. 2024. PMID: 39487576 Free PMC article.

9

Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening.

Huntington S, Smith JS, Nuttall D, Polokaova A, Smith PM, Hamlyn-Williams C, Adams E. Huntington S, et al. Future Oncol. 2024 Oct 24:1-12. doi: 10.1080/14796694.2024.2409625. Online ahead of print. Future Oncol. 2024. PMID: 39445605 Free article. Review.

10

Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma.

Straining R, Foss F, Schiffer M, Amin K, Agarwal S, Isufi I, Huntington S, Kothari S, Seropian S, Girardi M, Sethi T. Straining R, et al. Among authors: huntington s. Clin Lymphoma Myeloma Leuk. 2024 Sep 8:S2152-2650(24)01818-4. doi: 10.1016/j.clml.2024.09.005. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39368885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters